Correlation Between Apellis Pharmaceuticals and Rhythm Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Rhythm Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Rhythm Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Rhythm Pharmaceuticals, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Rhythm Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Rhythm Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Rhythm Pharmaceuticals.
Diversification Opportunities for Apellis Pharmaceuticals and Rhythm Pharmaceuticals
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Apellis and Rhythm is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Rhythm Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rhythm Pharmaceuticals and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Rhythm Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rhythm Pharmaceuticals has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Rhythm Pharmaceuticals go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and Rhythm Pharmaceuticals
Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to generate 1.23 times less return on investment than Rhythm Pharmaceuticals. But when comparing it to its historical volatility, Apellis Pharmaceuticals is 1.02 times less risky than Rhythm Pharmaceuticals. It trades about 0.19 of its potential returns per unit of risk. Rhythm Pharmaceuticals is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest 4,943 in Rhythm Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of 1,049 from holding Rhythm Pharmaceuticals or generate 21.22% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apellis Pharmaceuticals vs. Rhythm Pharmaceuticals
Performance |
| Timeline |
| Apellis Pharmaceuticals |
| Rhythm Pharmaceuticals |
Apellis Pharmaceuticals and Rhythm Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apellis Pharmaceuticals and Rhythm Pharmaceuticals
The main advantage of trading using opposite Apellis Pharmaceuticals and Rhythm Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Rhythm Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rhythm Pharmaceuticals will offset losses from the drop in Rhythm Pharmaceuticals' long position.| Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. HCW Biologics | Apellis Pharmaceuticals vs. Scpharmaceuticals | Apellis Pharmaceuticals vs. Milestone Pharmaceuticals |
| Rhythm Pharmaceuticals vs. Revolution Medicines | Rhythm Pharmaceuticals vs. Akero Therapeutics | Rhythm Pharmaceuticals vs. Avidity Biosciences | Rhythm Pharmaceuticals vs. Protagonist Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |